Cooperative Agreement U2CDK143946
- The Mountain States ASCEND Program is a $664,393 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to the University of Colorado-Denver, effective September 1, 2025. The overarching goal of this TL1 training program is to build an outstanding workforce of kidney, urologic, and hematologic (KUH) researchers through a collaborative, interdisciplinary, and team-based research training approach. The program will provide 6 predoctoral and 6...
- This Cooperative Agreement award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the NEXT GENERATION KUH RESEARCHERS (GENERATOR) project. The project aims to foster community and collaboration among trainees in the field of kidney, urological, and hematological (KUH) research. With a total funding amount of $368,742 spanning the award period from Sep 1,...
- The Houston Area Incubator for Kidney, Urologic, and Hematologic (HAI-KUH) Research Training Cooperative Agreement, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), will provide $368,743 to Baylor College of Medicine over a 5-year period from September 1, 2025 to May 31, 2030. The funding will support the development of a professional development program to enhance the skills and...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $882,138 to Baylor College of Medicine to develop the Houston Area Incubator for Kidney, Urologic and Hematologic Research Training (HAI-KUH). This program aims to build a highly qualified workforce to improve the health and quality of life of patients with kidney, urologic, and...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, awarded a $106,395 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The grant, running from September 1, 2025 to August 31, 2030, aims to further the development of individuals into future surgeon-scientists engaged in urology research careers. Key objectives include providing medical...
- This Project Grant award, valued at $188,428 and granted by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), supports an Interdisciplinary Training Program in Diabetes and Metabolism Research at the University of Arizona. The program aims to deliver a contemporary training experience in physiological diabetes research, applied research skills, community engagement, and career development. Key...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $882,138 Project Grant to Mayo Clinic under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, titled "NEXT GENERATION KUH RESEARCHERS (GENERATOR) TRAINING CORE", will fund a research and career development program focused on predoctoral and postdoctoral scholars in kidney, urologic, and hematologic (KUH) research. The 5-year project aims to create a...
- This Cooperative Agreement award of $2,367,892 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to develop and evaluate a novel approach to mitigate the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes (T1D) and chronic kidney disease (CKD) who are taking sodium-glucose cotransporter (SGLT) inhibitor medications. The project aims...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $414,267 Cooperative Agreement under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The goal of this 5-year project, titled "Polycystic Kidney Disease In Vitro Center (PKD-INVENT)", is to expand and enable the preclinical-to-clinical research pathway for polycystic kidney disease (PKD) by generating products, services, and...
- This Cooperative Agreement award of $422,478 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a project by the University of Florida and AdventHealth to complete recruitment and follow-up of a longitudinal prospective cohort of patients with acute, relapsing acute, and chronic pancreatitis. The objective is to establish a deeply phenotyped cohort with an associated annotated...
This $278,893 Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support the development of the "Mountain States Advancement in Research, Supportive Networking and Career Development (ASCEND)" program. The program aims to create a comprehensive training pathway to recruit, develop, and retain future academic leaders in the fields of kidney, urology, and hematology (KUH) research. Key components include establishing cross-disciplinary mentored training, expanding research opportunities, fostering effective mentorship and peer support, and supporting program evaluation. This 5-year award, running from September 1, 2025 to May 31, 2030, will be led by an interdisciplinary team at the University of Colorado and University of Utah, the premier research institutions in the Mountain West region.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $278.9k | 8/14/25 |